Matthews Asia Dividend (MAPIX), which was in the Kiplinger 25 for just over a year, has closed to most new investors. As is our custom, we are removing the fund, which returned 28.1% over the past year, from the Kip 25. Luckily, we didn�� have to go too far to find a worthy alternative: Matthews Asian Growth and Income (MACSX).
See Also: The Kiplinger 25 at a GlanceGrowth and Income has a more conservative mandate than the fund it replaces. Unlike Asia Dividend, which has nearly all of its assets in dividend-paying common stocks, Growth and Income invests in a mix of common stocks (83% of assets at last report), convertible bonds (11%) and preferred stocks (3%). Convertibles are hybrid securities that let you convert your holdings into the common stock of the issuing company at a preset price.
Top 5 Up And Coming Stocks To Buy Right Now: MGM Resorts International(MGM)
MGM Resorts International, through its subsidiaries, primarily owns and operates casino resorts in the United States. The company?s resorts offer gaming, hotel, dining, entertainment, retail, and other resort amenities. It also owns and operates golf courses and a golf club. As of December 31, 2010, the company owned and operated 15 properties located in Nevada, Mississippi, and Michigan; and has 50% investments in 4 other casino resorts in Nevada, Illinois, and Macau. In addition, MGM Resorts International has an agreement with the Mashantucket Pequot Tribal Nation, which owns and operates a casino resort in Connecticut, to carry the ?MGM Grand? brand name. The company was formerly known as MGM MIRAGE and changed its name to MGM Resorts International in June 2010. MGM Resorts International was founded in 1986 and is based in Las Vegas, Nevada.
Advisors' Opinion:- [By Lisa Abramowicz]
��t�� allowed companies such as ourselves to continue to access the capital markets,��Dan D��rrigo, the executive vice president and chief financial officer of Las Vegas-based casino company MGM Resorts International (MGM), said in a Sept. 17 telephone interview. During the crisis, ��e still had access but at much more costly rates to our company,��he said.
- [By Travis Hoium]
Now what: Online gaming is slowly being legalized across the U.S., with Nevada, New Jersey, and Delaware being the first to allow it. Boyd has a potentially lucrative partnership with bwin.party and MGM Resorts (NYSE: MGM ) , which could lead to huge profit growth, as I pointed out over a year ago. I wouldn't buy on this analyst upgrade alone, but the potential for online gaming is too big to ignore. I've built some estimates before (which can be seen here) and there's huge upside for both Boyd Gaming and MGM Resorts, but only if its legalized nationally. Until then, the potential for online gaming is minimal for Boyd.
Interested in more info on Boyd Gaming? Add it to your watchlist by clicking here. - [By Ted Stamas]
My impression is that unless they get acquired by one of the major casino operators like Las Vegas Sands (LVS) or MGM Resorts (MGM), this move into mobile gaming is a few years down the line before we see any significant results. Headlines can always goose a stock in the short term, but in the long run, it's the earnings that count, or revenue growth if you are a younger company. It must be noted that although they have a cash balance of $21.2 million and no debt, they are still losing money. This is a turnaround, speculative play, but one with significant potential.
- [By Suravi Thacker]
The gambling industry has been growing over the last few years, especially in Macau since it is the only region in China where gambling is legal. In fact, according to the Gaming Inspection and Coordination Bureau, Macau, revenue from this region has grown 20% in the first quarter of 2014. This increase has benefited most of the gambling companies, including MGM Resorts (MGM) and Wynn Resorts (WYNN).
Top Income Companies To Watch For 2014: Amgen Inc.(AMGN)
Amgen Inc., a biotechnology medicines company, discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada. The company markets recombinant protein therapeutics in supportive cancer care, nephrology, and inflammation. Its principal products include Aranesp and EPOGEN erythropoietic-stimulating agents that stimulate the production of red blood cells; Neulasta and NEUPOGEN to stimulate the production of neutrophils, which is a type of white blood cell that helps the body to fight infections; and Enbrel, an inhibitor of tumor necrosis factor that plays a role in the body?s response to inflammatory diseases. The company also markets other products comprising Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin (TPO) receptor agonist that mimics endogenous TPO, the primary driver of platelet production. In addition, it provides Denosumab, a human monoclonal antibody that targets RANKL, an essential regulator of osteoclasts. Further, the company offers product candidates in mid-to-late stage development in a variety of therapeutic areas, including oncology, hematology, inflammation, bone, nephrology, cardiovascular, and general medicine consisting of neurology. It markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies; consumers; and wholesale distributors of pharmaceutical products. The company has various collaborative arrangements with Pfizer Inc.; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Daiichi Sankyo Company, Limited; Array BioPharma Inc.; Kyowa Hakko Kirin Co. Ltd.; and Cytokinetics, Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Advisors' Opinion:- [By Maxx Chatsko]
Don't set sail without an anchor
Every portfolio needs a group of core holdings to weather out storms and net steady long-term gains. Amgen (NASDAQ: AMGN ) is an easy choice for any biotech portfolio. I was tempted to include Johnson & Johnson for its impressive suite of biologics on the market, but biotech investors may not want hip implants in their portfolio, so we'll stick with Amgen. The $80 billion behemoth has increased its focus in recent years by bringing intriguing compounds into its pipeline, and should have no problem heading higher for the long-term. - [By Bryan Murphy]
Names like Amgen, Inc. (NASDAQ:AMGN) and CEL-SCI Corporation (NYSEMKT:CVM) may have pioneered and even mainstreamed the idea of cancer immunology, but the nature of the branch of biotechnology means any company could send CEL-SCI or Amgen back-pedaling. See, it's not about size or deep pockets in the world of biotech anymore. It's about know-how and an idea, which can just as easily be discovered and developed by a small company as they can be a large company. That's why AMGN and CVM at least need to keep a close eye on budding immunology competitor TNI Biotech Inc. (OTCMKTS:TNIB).
- [By Ben Levisohn]
Who’d have thunk it? After lagging for much of the year, Gilead Sciences (GILD) is now outperforming the other big biotech stocks like Amgen (AMGN) and Biogen Idec (BIIB).
- [By Ben Levisohn]
Credit Suisse analyst�Ravi Mehrotra�and team raised Celgene to�Outperform from Neutral, putting it on par with Outperform rated Biogen Idec (BIIB) and�Gilead�(GILD) and a notch above Neutral-rated Amgen (AMGN).�
Top Income Companies To Watch For 2014: PolyOne Corp (POL)
PolyOne Corporation (PolyOne), incorporated on August 31, 2000, is a provider of specialized polymer materials, services and solutions with operations in specialty polymer formulations, color and additive systems, polymer distribution and specialty vinyl resins. The Company is a specialized developer and manufacturer of additives, liquid colorants, and fluoropolymer and silicone colorants. The Company offers approximately 52,000 polymer solutions to approximately 14,000 customers across the globe. The Company has 60 manufacturing sites and nine distribution facilities in North America, Europe, Asia and South America. The Company operates in four segments: Global Specialty Engineered Materials; Global Color, Additives and Inks; Performance Products and Solutions, and PolyOne Distribution. On January 3, 2011, the Company acquired Uniplen Industria de Polimeros Ltda. (Uniplen). In February 2011, the Company sold its 50% interest in SunBelt Chlor Alkali Partnership (SunBelt). On December 21, 2011, the Company acquired ColorMatrix Group, Inc. In December 2012, the Company acquired Glasforms Inc. Effective March 13, 2013, the Company acquired the interest of Spartech Corporation.
Global Specialty Engineered Materials
Global Specialty Engineered Materials is a provider of custom plastic formulations, services and solutions for designers, assemblers and processors of thermoplastic materials across a range of markets and end-use applications. Its product portfolio includes standard and custom formulated high-performance polymer compounds that are manufactured using thermoplastic compounds and elastomers, which are then combined with advanced polymer additive, reinforcement, filler, colorant and/or biomaterial technologies. The segment includes GLS Corporation (GLS). Global Specialty Engineered Materials has plants, sales and service facilities located throughout North America, Europe and Asia and South America.
Global Color, Additives and Inks
Global Color! , Additives and Inks is a provider of specialized color and additive concentrates, as well as inks and latexes. Its additive masterbatches encompass a range of performance enhancing characteristics and are commonly categorized by the function that they perform, such as ultra violet (UV) stabilization, anti-static, chemical blowing, antioxidant and lubricant, and processing enhancement. Its colorant and additives masterbatches are used in a range of plastics, including those used in food and medical packaging, transportation, building products, pipe and wire and cable markets. The Company also provides custom-formulated liquid systems that meet a variety of customer needs and chemistries, including vinyl, natural rubber and latex, polyurethane and silicone. Products include inks and latexes for diversified markets, including recreational and athletic apparel, construction and filtration, outdoor furniture and healthcare. Global Color, Additives and Inks has plants, sales and service facilities located throughout North America, Europe, Asia and North America.
Performance Products and Solutions
Performance Products and Solutions offers an array of products and services for vinyl coating, molding and extrusion processors principally in North America. Its product offerings include vinyl compounds, vinyl resins, and specialty coating materials based on vinyl. These products are sold to manufacturers of plastic parts and consumer-oriented products. The Company also offers a range of services, including materials testing and component analysis, custom compound development, colorant and additive services, design assistance, structural analyses, process simulations and extruder screw design. Vinyl is utilized across a range of applications in building and construction, wire and cable, consumer and recreation markets, transportation, packaging and healthcare. The segment also includes Producer Services, which offers custom compounding services to resin producers and processors that desig! n and dev! elop their own compound and masterbatch recipes.
PolyOne Distribution
The Company�� PolyOne Distribution business distributes approximately 3,500 grades of engineering and commodity grade resins, including PolyOne-produced compounds, to the North American market. These products are sold to approximately 5,700 custom injection molders and extruders who, in turn, convert them into plastic parts that are sold to end-users in a range of industries. Representing approximately 20 major suppliers, the Company offers its customers a product portfolio, just-in-time delivery from multiple stocking locations and local technical support. During the year ended December 31, 2011, the Company extended its distribution operations to Asia.
Advisors' Opinion:- [By Travis Hoium]
What: Shares of PolyOne (NYSE: POL ) jumped 10% today after the company reported earnings.
So what: First quarter revenue was up 7.5% to $801.1 million and adjusted earnings per share rose 29% to $0.31. Analysts expected higher revenue of $817.1 million but only $0.26 in earnings per share so the bottom line is what investors are excited about today. �
- [By Marc Bastow]
Specialized polymer materials manufacturer and distributor PolyOne (POL) raised its quarterly dividend 33% to 8 cents per share, payable on Jan. 9, 2014 to shareholders of record as of Dec. 17.
POL Dividend Yield: 0.97%
Top Income Companies To Watch For 2014: PulteGroup Inc. (PHA)
PulteGroup, Inc., through its subsidiaries, engages in homebuilding and financial services businesses primarily in the United States. The company�s homebuilding business includes the acquisition and development of land primarily for residential purposes within the United States; and the construction of housing on such lands. It offers various home designs, including single-family detached, townhouses, condominiums, and duplexes under the Pulte Homes, Del Webb, and Centex brand names. As of December 31, 2011, its homebuilding operations offered homes for sale in approximately 700 communities. The company�s financial services business consists of mortgage banking and title operations. It arranges financing through the origination of mortgage loans for its homebuyers; sells such loans and related servicing rights; and provides title insurance policies as an agent, and examination and closing services to its home buyers. The company was formerly known as Pulte Homes, Inc. an d changed its name to PulteGroup, Inc. in March 2010. PulteGroup, Inc. was founded in 1956 and is headquartered in Bloomfield Hills, Michigan.
Advisors' Opinion:- [By DailyFinance Staff]
LM Otero, AP The housing market has been leading the economic recovery, but have housing stocks hit the ceiling? They're jumping today after a very bullish report on housing starts: New construction projects last month topped the 1 million annual rate for the time since before the financial crisis began in 2008. That's lifted shares of leading homebuilders by two to four percent today, adding to the huge gains over the past year. KB Homes (KBH), Pulte (PHA) and Hovnanian (HOV) have all doubled in price over the past year. Lennar (LEN) is up 44 percent, D.R. Horton (DHI) is up 47 percent and Toll Brothers (TOL) 33 percent. Those gains have prompted several other builders to go public this year. Taylor Morrison Home (TMHC), Tri Pointe, and William Lyon Home have all moved higher since their IPOs. And even though there's plenty of optimism that housing will continue to lead the broader economic recovery, there's some concern that these stocks may slow down. Homebuilder stocks can no longer be considered cheap. So some analysts see alternate routes for investors looking to play the housing boom. One way is through home-improvement retailers, which benefit from sales of both new and existing homes. Other plays include lumber, furniture and appliance companies. It's also worth noting that today's report on home construction showed that starts of single-family homes actually declined in March. It was the more volatile multi-family sector that led the advance. But there may be some stock market opportunities in REITs – real estate investment trusts – which focus on apartments. Among the biggest ones are Post Properties, Essex Property Trust and Associated Estates. They make money from collecting monthly rents. And these stocks generally trade below the value of the properties they own. Even some builders known for single-family homes are moving into the multi-family segment. Lennar announced in January that it plans to enter the apartment rental mar
Top Income Companies To Watch For 2014: Home Bancorp Inc.(HBCP)
Home Bancorp, Inc. operates as the holding company for Home Bank that provides various banking services in Louisiana. The company offers various deposit products, including interest-bearing and noninterest-bearing checking, money market, savings, and negotiable order of withdrawal accounts; and demand deposit and certificates of deposit. It also provides various loan products, such as single-family residential first mortgage loans, commercial real estate mortgage loans, commercial loans, home equity loans and lines of credit, construction and land loans, and other loans. In addition, the company offers online banking, bank cards, and ATM services. As of December 31, 2010, it had 18 full-service banking offices in the Greater Lafayette, Baton Rouge, and Northshore regions of south Louisiana. The company was founded in 1908 and is headquartered in Lafayette, Louisiana.
Advisors' Opinion:- [By Tim Melvin]
The credit crisis slowed the pace of deals temporarily, but there are plenty of former thrifts trading at low valuations that have the potential for large long-term returns.
Home Bancorp (HBCP)Home Bancorp (HBCP) is a 22-branch bank located in Lafayette, La. The bank has almost $1 billion in assets and the balance sheet is in excellent condition. Also, its equity-to-asset ratio is 14.5 — well above my preferred minimum of 10. Meanwhile, Home Bancorp’s nonperforming assets are just 2.09% of the total.
No comments:
Post a Comment